The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006

References

• Niculescu T, Hochberg MC. Epidemiology. In: Moreland L, ed. Rheumatoid Arthritis. Philadelphia: Lippincott, Williams & Wilkins, 2007, in press
   Google Scholar
• Lindqvist E, Saxne T, Geborek P, Eberhardt K. Ten year outcome in a cohort of patients with early rheumatoid arthritis: health status, disease process, and damage. Ann Rheum Dis 2002;61:1055–9
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Crowson CS, O’Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arthritis Rheum 1999;42: 415–20
   Google Scholar
• Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 2004;33:65–72
   PubMed Web of Science ®Google Scholar
• Mikuls TR. Co-morbidity in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:729–52
   PubMed Web of Science ®Google Scholar
• Turesson C, O’Fallon WM, Crowson CS, et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722–7
   PubMed Web of Science ®Google Scholar
• Carmona L, Gonzalez-Alvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897–900
   PubMed Web of Science ®Google Scholar
• Cimmino MA, Salvarani C, Macchioni P, et al. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000;19:213–17
   PubMed Web of Science ®Google Scholar
• Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668–74
   PubMed Web of Science ®Google Scholar
• Turesson C, O’Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62–7
   PubMed Web of Science ®Google Scholar
• Erhardt CC, Mumford PA, Venables PJ, Maini RN. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7–13
   PubMed Web of Science ®Google Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011–23
   PubMed Web of Science ®Google Scholar
• Andrews NC. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 2004;113:1251–3
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002;64:604–11
   PubMed Web of Science ®Google Scholar
• Collado-Hidalgo A, Bower JE, Ganz PA, et al. Inflammatory biomarkers for persistent fatigue in breast cancer survivors. Clin Cancer Res 2006;12:2759–66
   PubMed Web of Science ®Google Scholar
• Jurik AG, Graudal H. Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int 1986;6:37–42
   PubMed Web of Science ®Google Scholar
• Wilkinson M, Kirk J. Leg ulcers complicating rheumatoid arthritis. Scott Med J 1965;10:175–82
   PubMedGoogle Scholar
• Sibley JT, Haga M, Visram DA, Mitchell DM. The clinical course of Felty’s syndrome compared to matched controls. J Rheumatol 1991;18:1163–7
   PubMed Web of Science ®Google Scholar
• Turesson C, McClelland RL, Christianson TJ, Matteson EL. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum 2004;50:3729–31
   PubMed Web of Science ®Google Scholar
• Hara KS, Ballard DJ, Ilstrup DM, et al. Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore) 1990;69:81–91
   PubMed Web of Science ®Google Scholar
• Watts RA, Carruthers DM, Symmons DP, Scott DG. The incidence of rheumatoid vasculitis in the Norwich Health Authority. Br J Rheumatol 1994;33:832–3
   PubMedGoogle Scholar
• Kuehn BM. Better osteoporosis management a priority: impact predicted to soar with aging population. JAMA 2005;293:2453–8
   PubMed Web of Science ®Google Scholar
• Litwin MS, Saigal CS, Yano EM, et al. Urologic diseases in America Project: analytical methods and principal findings. J Urol 2005;173:933–7
   PubMed Web of Science ®Google Scholar
• Berndt E, Crown W, Kallich J, et al. The impact of anaemia and its treatment on employee disability and medical costs. Pharmacoeconomics 2005;23:183–92
   PubMed Web of Science ®Google Scholar
• Han C, Zhao N, Gaslightwala A, Bala M. An epidemiological and healthcare utilisation study of rheumatoid arthritis in an adult population in the US. J Med Econ 2007;10:489–99
   Google Scholar
• Ozminkowski RJ, Burton WN, Goetzel RZ, et al. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. J Occup Environ Med 2006;48:135–48
   PubMed Web of Science ®Google Scholar
• Nissenson AR, Wade S, Goodnough T, et al. Economic burden of anemia in an insured population. J Manag Care Pharm 2005;11:565–74
   PubMedGoogle Scholar
• Wolfe F, Michaud K, Chakravarty EF. Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders. Rheumatology (Oxford) 2006;45:1370–5
   Google Scholar
• Matteson EL. Extra-articular features of rheumatoid arthritis and systemic involvement. In: Hochberg MC, Silman AJ, Smolen JS, et al., eds. Rheumatoid Arthritis. Edinburgh: Mosby, 2003:781–92
   Google Scholar
• Cox DR. Regression models and life tables. J R Stat Soc B 1972;34:187–220
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613–19
   Google Scholar
• Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197–203
   Google Scholar
• Calguneri M, Ureten K, Akif Ozturk M, et al. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 2006;24:305–8
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328–46
   PubMed Web of Science ®Google Scholar
• Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381–90
   Google Scholar
• Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007;146:406–15
   Google Scholar
• Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34–45
   PubMed Web of Science ®Google Scholar
• Gabriel SE, Crowson CS, Kremers HM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54–8
   PubMed Web of Science ®Google Scholar
• Alkaabi JK, Ho M, Levison R, Pullar T, Belch JJ. Rheumatoid arthritis and macrovascular disease. Rheumatology (Oxford) 2003;42:292–7
   PubMedGoogle Scholar
• Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004;63:952–5
   Google Scholar
• Watson DJ, Rhodes T, Guess HA. All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database. J Rheumatol 2003;30:1196–202
   Google Scholar
• Liang KP, Liang KV, Matteson EL, et al. Incidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extra-articular disease manifestations. Arthritis Rheum 2006;54:642–8
   PubMed Web of Science ®Google Scholar
• Warrington KJ, Kent PD, Frye RL, et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther 2005;7:R984–91
   PubMed Web of Science ®Google Scholar
• Peeters HR, Jongen-Lavrencic M, Raja AN, et al. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis 1996;55:162–8
   PubMed Web of Science ®Google Scholar
• Dequeker J, Maenaut K, Verwilghen J, Westhovens R. Osteoporosis in rheumatoid arthritis. Clin Exp Rheumatol 1995;13(Suppl 12):S21–6
   PubMedGoogle Scholar
• Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49–52
   PubMedGoogle Scholar
• van Staa TP, Geusens P, Bijlsma JW, et al. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104–12
   PubMed Web of Science ®Google Scholar
• Choy EH, Isenberg DA, Garrood T, et al. Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 2002;46:3143–50
   PubMed Web of Science ®Google Scholar
• Arend WP. Physiology of cytokine pathways in rheumatoid arthritis. Arthritis Rheum 2001;45:101–6
   PubMed Web of Science ®Google Scholar
• Emery P, Gabay C, Kraan M, Gomez-Reino J. Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis. Rheumatol Int 2007;27:793–806
   Google Scholar
• Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722–32
   PubMed Web of Science ®Google Scholar
• Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000;75:369–80
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 1999;138:S419–20
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the role of inflammation and infection. Histopathology 2007;50:535–46
   Google Scholar
• Liang KW, Sheu WH, Lee WL, et al. Coronary artery disease progression is associated with C-reactive protein and conventional risk factors but not soluble CD40 ligand. Can J Cardiol 2006;22:691–6
   PubMed Web of Science ®Google Scholar
• Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417–24
   PubMed Web of Science ®Google Scholar
• Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998;31:1460–5
   PubMed Web of Science ®Google Scholar
• Haverkate F, Thompson SG, Pyke SD, et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina.European ConcertedAction onThrombosis andDisabilities Angina Pectoris Study Group. Lancet 1997;349:462–6
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Kritikos HD, Valatas V, et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 2002;100:474–82
   PubMed Web of Science ®Google Scholar
• Davis D, Charles PJ, Potter A, et al. Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade. Br J Rheumatol 1997;36:950–6
   PubMedGoogle Scholar
• Jongen-Lavrencic M, Peeters HR, Wognum A, et al. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol 1997;24:1504–9
   Google Scholar
• Teitelbaum SL. Osteoclasts: culprits in inflammatory osteolysis. Arthritis Res Ther 2006;8:201
   PubMed Web of Science ®Google Scholar
• Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 2005;115: 282–90
   Google Scholar
• Jonsson T, Arinbjarnarson S, Thorsteinsson J, et al. Raised IgA rheumatoid factor (RF) but not IgM RF or IgG RF is associated with extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 1995;24:372–5
   PubMed Web of Science ®Google Scholar
• Odegard S, Landewe R, van der Heijde D, et al. Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients. Arthritis Rheum 2006;54: 68–75
   Google Scholar
• Turesson C, Jacobsson LT, Sturfelt G, Matteson EL, Mathsson L, Ronnelid J. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis 2007;66:59–64
   PubMed Web of Science ®Google Scholar
• Turesson C, Schaid DJ, Weyand CM, et al. The impact of HLADRB1 genes on extra-articular disease manifestations in rheumatoid arthritis. Arthritis Res Ther 2005;7:R1386–93
   PubMed Web of Science ®Google Scholar
• Tobacco use among adults – United States, 2005. MMWR Morb Mortal Wkly Rep 2006;55:1145–8
   PubMedGoogle Scholar
• MacLean CH, Park GS, Traina SB, et al. Positive predictive value (PPV) of an administrative data-based algorithm for the identification of patients with rheumatoid arthritis (RA). Arthritis Rheum 2001;44:S106 (Abstract 324)
   Google Scholar